MedTrace Logo

Progesterone Support of FET

NCT01058382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2013-05-10

No results posted yet for this study

Summary

There have been two very common forms of progesterone administration that have been used during ovulation induction, in vitro fertilization (IVF) and embryo transfers. There are currently no randomized clinical trials to demonstrate which method of progesterone administration is more effective for frozen embryo transfer. We raise the question: Is there a difference between the two accepted methods of progesterone administration, intramuscular and vaginal suppositories, for frozen embryo transfer? Studies for fresh embryo transfer after in vitro fertilization, have demonstrated that there is not a difference between the two methods of progesterone administration. We will evaluate the question for frozen embryo transfer.

Conditions

  • Frozen Embryo Pregnancy Rate

Interventions

DRUG

Progesterone Vaginal Suppositories

Progesterone Vaginal Suppositories 200 mg three times daily for 10 weeks following embryo transfer

DRUG

Intramuscular Progesterone-in-Oil

Progesterone-in-Oil 50 mg IM once daily for 10 weeks following embryo transfer

Sponsors & Collaborators

  • Charles Coddington

    lead OTHER

Principal Investigators

  • Charles Coddington, MD · Mayo Clinic

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01058382 on ClinicalTrials.gov